Benzinga's Volume Movers

shares climbed 49.33% to $25.02. The volume of Dyax shares traded was 2784% higher than normal. Dyax said a Phase Ib trial of its DX-2930 drug met safety goals and demonstrated statistically significant reductions in attack rates of hereditary angiodema, a rare disease.

surged 9% to $22.05. The volume of Trillium Therapeutics shares traded 1563% higher than normal. Trillium Therapeutics priced a 1.52 million share common stock offering at $19.50 per share.

shares moved up 3.09% to $17.00. The volume of Media General traded was 702%higher than normal. Media General priced secondary public offering of 6.8 million shares of common stock by selling stockholder at $16 per share.

shares rose 7.52% to $44.49. The volume of Sears Holdings shares traded was 443% higher than normal. Sears Holdings and

announced a 50-50 joint venture.